相关实验视频
Updated: Sep 23, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
15.9K
耐火性原发性免疫血栓塞缩症的标志物
Guillaume Moulis1,2, Lamya Garabet3
1Department of Internal Medicine, Referral Center for Autoimmune Cytopenia, Toulouse University Hospital, Toulouse, France.
British journal of haematology
|November 29, 2023
概括
耐火性免疫性血小板缺血症 (ITP) 很难治疗. 本综述研究了预测切除术治疗失败的因素,TPO-RAs,rituximab和 fostamatinib在ITP患者中.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 免疫性血小板缺血 (ITP) 是一种自身免疫性疾病,其特征是血小板数量较低.
- 耐火性ITP带来了重大治疗挑战,通常是由对标准疗法的不响应来定义的.
- 确定预测治疗结果的因素对于患者管理至关重要.
研究的目的:
- 审查和综合有关与关键ITP治疗的折射性相关的临床和生物因素的证据.
- 讨论与脊髓切除术,血栓形成素受体激动剂 (TPO-RAs),rituximab和 fostamatinib不良结果相关的因素.
- 探索多反射性ITP的预测因素,这种疾病是一种严重的形式.
主要方法:
- 对现有证据进行系统审查.
- 对影响治疗反应的临床和生物因素的分析.
- 评论与特定疗法和多重耐火ITP的折射性相关的因素.
主要成果:
- 关于预测脊髓切除术的折射性,TPO-RAs,rituximab和 fostamatinib的因素的证据.
- 讨论了与治疗失败相关的特定临床和生物标志物.
- 确定了导致多反射性ITP的因素.
结论:
- 了解折射性预测因素对于优化ITP治疗策略至关重要.
- 需要进一步的研究来阐明耐火ITP治疗失败的机制.
- 个性化治疗方法可以改善耐火性免疫性血栓塞缩小症患者的治疗结果.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...